RESUMEN
The objective of our study was to evaluate the knowledge of alcohol as a risk factor for liver disease among patients with chronic hepatitis C who have achieved a sustainable viral response (SVR) after receiving direct antiviral medication (DAA). The study cohort included patients from the Hepatitis C Elimination Program treated with directMethods: antiviral drugs (DAA) in Tbilisi (Georgia). A total of 210 patients were studied. Data were processed in the statistical program SPSS26. The Student's t-test was used. P-value less than 0.05 was considered statistically significant. Results: The study was conducted in 2021. These data were collected before and during treatment. The majority had used alcohol during their lifetime. 12.5% of males think that taking more than 10 glasses of alcohol is normal for health. Older age and higher education were positively associated with respondents' awareness regarding outcomes of heavy alcohol drinking (p < 0.01)